Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

NCT03093324

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Tucson, Arizona, United States
  • Alkermes Investigational Site Long Beach, California, United States
View all 67 locations
View Trial Details
Completed

A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)

NCT03606460

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • University of Colorado; Anschutz Medical Campus Department of Neurology Aurora, Colorado, United States
  • Dragonfly Research, LLC Wellesley, Massachusetts, United States
  • Cleveland Clinic Fndn Cleveland, Ohio, United States
  • Ohio Health Research Institute Grant Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions